Retham Technologies LLC

Website
1225 Discovery Pkwy
Milwaukee, WI 53226
https://www.rethamtechnologies.com

Retham Technologies LLC, based in Milwaukee, WI, is a pioneering company dedicated to revolutionizing the diagnosis and management of Heparin-induced Thrombocytopenia (HIT). Their mission is to develop a technically-simple in vitro diagnostic (IVD) test called HITDx, which aims to provide accurate and timely diagnosis of HIT, ultimately reducing morbidity, saving lives, and lowering the cost of care for HIT-suspected patients.

Established in 2017, Retham Technologies is committed to translating recent discoveries into a life-saving IVD assay that offers earlier and more precise in-hospital diagnosis of HIT. With the goal of improving patient outcomes, their innovative HITDx test is expected to facilitate timely and appropriate therapy, leading to better overall results for individuals affected by this serious adverse reaction to the blood thinner heparin.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Immucor GTI Diagnostics, Inc

Immucor GTI Diagnostics, Inc in Waukesha is committed to providing products that facilitate safe, accessible, and affordable matches for patients requiring blood or organ transplants. Their dedication ensures that individuals in need receive the right match, promoting optimal outcomes and improving the quality of care in the medical field. Generated from their website's infomation

Cytegen Corp

Cytegen Corp is a technology company based in Milwaukee, WI, specializing in innovative solutions for data management and analysis. With a focus on cutting-edge research and development, Cytegen Corp provides tailored software and services to help businesses optimize their operations and make data-driven decisions. Generated from their business information
Testing laboratories

RPRD Diagnostics LLC

RPRD Diagnostics LLC, based in Milwaukee, WI, is a leading provider of comprehensive pharmacogenomics solutions, specializing in precision health testing for individuals of diverse ethnic backgrounds. Their range of services includes whole pharmacogenomics scans, targeted panels, and next-generation sequencing, offering valuable insights into important pharmacogenes. With a focus on preemptive pharmacogenomics, RPRD Diagnostics collaborates with healthcare providers to deliver evidence-based clinical solutions for personalized medicine. Their dedication to advancing pharmacogenomics research and testing ensures patients receive tailored treatment plans based on their genetic profiles.Generated from the website
United States›Wisconsin›Milwaukee›Retham Technologies LLC

Partial Data by Infogroup (c) 2025. All rights reserved.